Fresenius Kabi Oncology has informed that the board of directors of the company at its meeting held on February 02, 2012, has taken on record the resignation of Anand C. Burman as the non-executive director of the company with effect from February 02, 2012.
The above information is part of company’s filing submitted to the BSE.